Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding

Kidney International

Volumn 55, Issue 5, 1999, Pages 1991-1997

  Palsson, Runolfur ^a   Niles, John L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anticoagulation; Blood flow; Clotting; Continuous renal replacement therapy; CVVH; Heparinization

Indexed keywords

CITRIC ACID; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CRITICAL ILLNESS; ELECTROLYTE BALANCE; EXTRACORPOREAL CIRCULATION; FEMALE; FILTER; FLUID BALANCE; HEMOFILTRATION; HEPARINIZATION; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; UREMIA;

EID: 0032944876     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00444.x     Document Type: Article

References (30)

1. 1. KRAMER P, WIGGER W, RIEGER J, MATTHALI D, SCHELER F: Arteriovenous hemofiltration: A new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 55:1121-1122, 1977
2. 2. LAUER A, SACCAGGI A, RONCO C, BELLEDONNE M, GLABMAN S, BOSCH JP: Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 99:455-460, 1983
3. 3. KAPLAN AA, LONGNECKER RE, FOLKERT VW: Continuous arteriovenous hemofiltration: A report of six months experience. Ann Intern Med 100:358-367, 1984
4. 4. SCHNEIDER NS, GERONEMUS RP: Continuous arteriovenous hemodialysis. Kidney Int 5:159-162, 1988
5. 5. BARZILAY E, WEKSLER N, KESSLER D, PREGO J: The use of continuous arterio-venous hemodialysis in the management of patients with oliguria associated with multiple organ failure. J Intensive Care Med 3:444-445, 1988
6. 6. BELLOMO R, BOYCE N: Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J 39:M794-M797, 1993
7. 7. STORCK M, HARTL WH, ZIMMERER E, INTHORN D: Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337:452-455, 1991
8. 8. BELLOMO R, PARKIN G, LOVE J, BOYCE N: A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 21:400-404, 1993
9. 9. CLARK WR, ALAKA KJ, MUELLER BA, MACIAS WL: A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 4:1413-1420, 1994
10. 10. MEHTA RL, MCDONALD BR, AGUILAR MM, WARD DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981, 1990
11. 11. WARD DM, MEHTA RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 43(Suppl 41):S237-S244, 1993
12. 12. Deleted in proof
13. 13. SAMUELSSON O, AMIRAL J, ATTMAN PO, BENNEGÅRD K, BJÖRCK S, TENGBORN L: Heparin-induced thrombocytopenia during continuous haemofiltration. Nephrol Dial Transplant 10:1768-1771, 1995
14. 14. PAGANINI EP: Slow continuous hemofiltration and slow continuous Ultrafiltration. ASAIO Trans 34:63-66, 1988
15. 15. KAPLAN AA, PETRILLO R: Regional heparinization for continuous arterio-venous hemofiltration. ASAIO Trans 33:312-315, 1987
16. 16. HORY B, CACHOUX A, TOULEMONDE F: Continuous arteriovenous hemofiltration with low-molecular-weight heparin. (letter) Nephron 42:125, 1985
17. 17. PONIKVAR R, KANDUS A, BUTUROVIC J, KVEDER R: Use of prostacyclin as the only anticoagulant during continuous veno-venous hemofiltration. Contrib Nephrol 93:218-220, 1991
18. 18. OHTAKE Y, HIRASAWA H, SUGAI T, ODA S, SHIGA H, MATSUDA K: Nafamostat mesilate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 93:215-217, 1991
19. 19. MORITA Y, JOHNSON RW, DORN RE, HALL DS: Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242:32-42, 1961
20. 20. PINNICK RV, WIEGMANN TB, DIEDERICH DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308:258, 1988
21. 21. KIRSCHBAUM B, GALISHOFF M, REINES HD: Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation. Crit Care Med 20:349-353, 1992
22. 22. AHMAD S, YEO K, JENSEN W, LANDICHO D, GREGORY B, MORITZ JL, KENNY M: Citrate anticoagulation during in vivo simulation of slow hemofiltration. Blood Purif 8:177-182, 1990
23. 23. MANNS M, SIGLER M, TEEHAN B: Continuous renal replacement therapies: An update. Am J Kidney Dis 32:185-207, 1998
24. 24. KNAUS W, DRAPER E, WAGNER D, ZIMMERMAN J: APACHE II: A severity of disease classification system. Crit Care Med 13:818-829, 1985
25. 25. MARTIN P-Y, CHEVROLET J-C, SUTER P, FAVRE H: Anticoagulation in patients treated by continuous venovenous hemofiltration: A retrospective study. Am J Kidney Dis 24:806-812, 1994
26. 26. STEFANIDIS I, HAGEL J, FRANK D, MAURIN N: Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure. Clin Nephrol 46:199-205, 1996
27. 27. JENKINS RD, KÜHN RJ, FUNK JE: Permeability decay in CAVH hemofilters. ASAIO Trans 34:590-593, 1988
28. 28. SIGLER MH, TEEHAN BP: Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int 32:562-571, 1987
29. 29. CAMERON J: Acute renal failure thirty years on. Q J Med 74:1-2, 1990
30. 30. MEHTA R: Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 14:64-82, 1994